Viewing data from:

FLURBIPROFEN SODIUM

ANDA

FLURBIPROFEN SODIUM | A074447 | BAUSCH AND LOMB INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Flurbiprofen Sodium (2023)

Total Spending

$681K

Total Claims

14,608

Beneficiaries

8,299

Avg Cost/Unit

$11.87

Spending Trend

$499K(2019)→$502K(2020)→$649K(2021)→$645K(2022)→$681K(2023)

YoY Change:-5.1%

5yr CAGR:+3.1%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain1 active DMF1 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

SHANGHAI WONDER PHARMACEUTICAL CO LTDFLURBIPROFEN SODIUM

DMF 397002024

WYCKOFF CHEMICAL CO INCInactiveFLURBIPROFEN SODIUM

DMF 102481993

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 0.03%

0 patents0 exclusivities▴

SOLUTION/DROPS;OPHTHALMIC | Approved: Jan 4, 1995

No patent or exclusivity listings for this strength.